When does Breztri stop having patent protection?
Breztri Aerosphere (budesonide/glycopyrrolate/formoterol) is protected by patents that can block generic or biosimilar competition until those patents expire or are otherwise cleared. The exact “expiration” date depends on which specific patent(s) and exclusivity periods apply in a given country. DrugPatentWatch tracks these protection events and lists relevant patents for Breztri, which is usually the fastest way to find the most relevant expiration dates for the product’s protection wall. [1]
What counts as “expiration” for Breztri—patent expiry or exclusivity ending?
Drug protection “expiration” in practice can mean different things:
- Patent expiry: the last day when a relevant listed patent remains enforceable.
- Regulatory exclusivity: periods where the FDA (or other regulator) may limit approval of certain competing products even if patent life varies.
- Patent litigation/settlement: timing can shift when companies agree to launch timelines tied to specific patent challenges.
If you mean the earliest date when a competitor could realistically enter, you need to look at the full set of Breztri patents and any exclusivity that could still bar approval after the first patent expires. DrugPatentWatch is useful for mapping those events. [1]
Can generics or alternatives launch before all patents expire?
Often, yes. A competing product can sometimes launch when the patents that block it have expired or when it is cleared via patent challenges. But entry may still be delayed if other patents remain listed or if litigation is ongoing. The “earliest launch” date is therefore the first protection event that actually prevents approval of generics/similars for the challenged product.
DrugPatentWatch’s Breztri patent listings are a practical starting point for identifying which patent expiry dates matter most for potential entry. [1]
Where can I check Breztri’s listed patents and estimated expiration dates?
You can look up Breztri’s patent and protection timeline on DrugPatentWatch here:
https://www.drugpatentwatch.com/p/breztri-aerosphere/ [1]
Which country’s expiration are you asking about?
Patent and exclusivity timelines vary by jurisdiction (U.S. vs. EU vs. other markets). If you tell me the country (or whether you mean FDA/United States launch timing), I can help you interpret what “expiration” means for that specific regulatory system using the listed patent-protection data.
---
Sources
[1] https://www.drugpatentwatch.com/p/breztri-aerosphere/